Point72 Hong Kong LTD Dynavax Technologies Corp Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.45 - $12.83 $69,895 - $120,371	-9,382 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.75 - $14.44 $91,474 - $135,476	9,382 New	9,382 $102,000
Q3 2021 Nov 15, 2021	SELL	$9.16 - $19.83 $4,506 - $9,756	-492 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.25 - $10.99 $935 - $1,417	129 Added 35.54%	492 $5,000
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $1,658 - $4,058	363 New	363 $4,000
Q3 2019 Nov 14, 2019	SELL	$2.69 - $4.85 $589 - $1,062	-219 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.65 - $7.89 $799 - $1,727	219 New	219 $1,000
Q4 2018 Feb 14, 2019	SELL	$8.14 - $13.28 $19,202 - $31,327	-2,359 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.85 - $16.0 $25,797 - $34,832	2,177 Added 1196.15%	2,359 $29,000
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $2,757 - $3,776	182 New	182 $3,000

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.6B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.